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ABSTRACT
The developing vertebrate embryo is exquisitely sensitive to retinoic
acid (RA) concentration, particularly during anteroposterior patterning.
In contrast to Nodal and Wnt signaling, RA was not previously
considered to be an instructive signal in mesoderm formation
during gastrulation. Here, we show in Xenopus that RARγ is
indispensable for the expression of early mesoderm markers and
is, therefore, an obligatory factor in mesodermal competence and/
or maintenance. We identified several novel targets upregulated by
RA receptor signaling in the early gastrula that are expressed in the
circumblastoporal ring and linked to mesodermal development.
Despite overlapping expression patterns of the genes encoding the
RA-synthesizing enzyme Aldh1a2 and the RA-degrading enzyme
Cyp26a1, RARγ1 functions as a transcriptional activator in early
mesoderm development, suggesting that RA ligand is available to
the embryo earlier than previously appreciated. RARγ1 is required
for cellular adhesion, as revealed by spontaneous dissociation and
depletion of ncam1 mRNA in animal caps harvested from RARγ1
knockdownembryos.RARγ1 knockdownobliterates somite boundaries,
and causes loss of Myod protein in the presomitic mesoderm, but
ectopic, persistent expression of Myod protein in the trunk. Thus,
RARγ1 is required for stabilizing the mesodermal fate, myogenic
commitment, somite boundary formation, and terminal skeletal
muscle differentiation.
KEY WORDS: Adhesion, Mesoderm, RARγ, Retinoic acid signaling,
Somitogenesis, Xenopus
INTRODUCTION
Retinoic acid (RA) is a signaling molecule present at discrete
concentrations in precise locations throughout the developing
embryo, activating gene expression where RA receptors (RARs)
are expressed. The RARs are a family of three genes that encode
receptor subtypes RARα, β and γ, which are ligand-modulated
transcription factors in the nuclear hormone receptor superfamily
(reviewed by Maden, 2007; Evans and Mangelsdorf, 2014). Where
RA is absent, RARs can also function as unliganded repressors
(Janesick et al., 2014). RARs possess a range of activities and
developmental functions that depend on the local concentration of
RA, the spatial distribution of each RAR subtype (α, β or γ) and the
availability of co-activator and co-repressor proteins (Rochette-Egly
and Germain, 2009).
RAR signaling is implicated in numerous developmental
processes, including patterning and boundary-setting, proliferation/
differentiation and organogenesis (Niederreither et al., 2001;Maden,
2007; Rhinn and Dolle, 2012; Janesick et al., 2013; Cunningham
and Duester, 2015). RA is essential for the development of many
non-axial mesodermal derivatives, in particular the heart, somites
and kidney (Niederreither et al., 2001; Moreno and Kintner, 2004;
Naylor et al., 2016). We previously showed that liganded RARβ2 in
the trunk is required for somite patterning and number, hypaxial
muscle migration, and restriction of the presomitic mesoderm,
whereas unliganded RARγ maintains the size of the presomitic
mesoderm and the pool of bipotential caudal progenitor cells
(Janesick et al., 2014, 2017).
Early studies revealed that RA is unable to instruct naive
ectoderm to become mesoderm. Animal caps (ectodermal explants)
fail to elongate in the presence of RA (Ruiz i Altaba and Jessell,
1991; Sive and Cheng, 1991); therefore, RA signaling was not
considered to have an instructive role in mesoderm formation.
Furthermore, the RA-synthesizing enzyme Aldh1a2 and RA
receptors are not vegetally enriched (De Domenico et al., 2015)
where mesoderm inducers are located; therefore, these are
unlikely to be endogenous mesoderm-inducing factors. Instead,
it has been shown that RA influences mesoderm patterning after
gastrulation, acting to suppress anterior and dorsal characteristics
(Ruiz i Altaba and Jessell, 1991; Sive and Cheng, 1991).
Nevertheless, the expression of RARγ in the circumblastoporal
region of the early gastrula embryo (Pfeffer and De Robertis,
1994) led us to ask whether RA signaling is functioning earlier
than initially thought.
The importance and existence of competence ormaintenance factors
located in the responding marginal zone has become increasingly
recognized (Fletcher and Harland, 2008). It is conceivable that
RARγ signaling could be such a factor, given its expression in the
marginal zone, although this has not previously been addressed.
Here, we provide evidence supporting a novel role for RARγ
signaling in mesoderm formation. We show that the function of
RARγ in mesoderm patterning after gastrulation is preceded by an
earlier phase in which RARγ modulates the expression of wnt8,
brachyury (tbxt; also known as T ), gdf3 and fgf8 in the gastrula-
stage embryo. Using RNA-seq, we identify several novel genes
expressed in the circumblastoporal region that are upregulated by
RAR signaling. We show that RARγ signaling is required for the
maintenance of Myod protein in the presomitic mesoderm (PSM)
domain and also find that RARγ knockdown stabilizes the muscle
progenitor state, producing ectopic Myod+ cells in the trunk and
impeding somite maturation.Received 21 August 2017; Accepted 31 July 2018
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RESULTS
RARγ1 is required much earlier in development than
previously characterized
In 2002, Carrasco and colleagues first demonstrated that loss of
retinoic acid receptor gamma 1 (RARγ1) abolished brachyury (T )
and foxa4 (pintallavis) expression on the injected side (Fig. S1;
Franco, 2002). Hence, we hypothesized that the presence of RARγ
is required for the mesodermal competence or maintenance. RARγ
is expressed in the circumblastoporal domain during gastrula stages,
as are the genes encoding both the RA-synthesizing enzyme
Aldh1a2 and the degradation enzyme Cyp26a1 (Fig. S2). Therefore,
components of RA signaling are found in the correct time and place to
regulate mesoderm development. We designed a second morpholino
(MO) to Xenopus laevis RARγ1 in addition to the original MO used
in Fig. S1, and validated specificity of the phenotype on T expression
(Fig. S3). Loss of RARγ1 does not completely derail gastrulation
(except at high MO doses), but strongly downregulates expression of
genes wnt8, gdf3 and fgf8 in signaling pathways (Wnt, Nodal, Fgf)
that are crucial for regulating mesoderm formation (Fig. 1A-D). This
effect is selective for the RARγ subtype, as RARαMOs do not affect
these markers (Fig. 1E-G), and rarb is not detectable at gastrula
stages (Janesick et al., 2017). To be certain that the RARα
morpholino was functional, we verified in the same clutch of
embryos that RARα knockdown strongly inhibited expression of
N-tubulin (tubb2b) at stage 14 (Fig. 1H) as we previously showed
(Janesick et al., 2013).
Novel RA-responsive mesodermal genes are identified by
RNA-seq in Xenopus laevis
We conducted transcriptomal analysis (Fig. S4) of gastrula-stage
embryos that had been treated at early blastula (stage 6/7) with the
RAR-selective agonist TTNPB, the RAR-selective antagonist
AGN193109, or 0.1% ethanol vehicle control. We identified 135
differentially regulated genes (after reducing .L or .S homeolog
pairs to one gene symbol) upregulated by TTNPB compared
with control (Benjamini–Hochberg false discovery rate q<0.05,
FPKMVEH> 0.1, fold change>1.5) (Table S1). We identified four
genes significantly downregulated by TTNPB [orthodenticle
homeobox 2 and 5 (also known as cone-rod homeobox), ADAM
metallopeptidasewith thrombospondin type 1motif 1 and betacellulin],
and no genes significantly regulated by AGN193109. If we employ
a less-stringent P-value, the number of differentially expressed
genes is substantially increased. However, we aimed for 100%
validation by in situ hybridization, and therefore selected the more
stringent q-value cut-off in these studies.
We used gene ontology (GO) analysis to assess the types of genes
regulated by TTNPB in gastrula embryos and identified terms highly
enriched for genes involved in known developmental roles of RA,
such as regulation of homeobox proteins, embryonic morphogenesis,
regionalization and patterning (Fig. 2A). Antennapedia-type
homeobox genes are not typically expressed in control embryos at
gastrulation, but were turned on prematurely by TTNPB (Fig. 2A). A
number ofWnt signaling genes are upregulated by TTNPB, including
some that promote signaling (wnt5b, frizzled class receptor 4 and
10) as well as some that antagonize signaling [dishevelled-binding
antagonist of beta-catenin 1 (dact1), kringle containing transmembrane
protein 2 (kremen2) and zinc finger protein 703 (znf703)]. GO
terms for neural crest, ear and hindbrain development are also
highly enriched (Fig. 2A).
We selected genes for further study based on three criteria: (1)
novelty (RA targets not previously characterized), (2) potential role
in mesoderm development (e.g. connection to Nodal, Wnt, Fgf or
Bmp pathways), or (3) regulation of mesodermal derivatives at later
stages. Fig. 2B shows the FPKM values for selected genes, and we
note that the expression of the .L and .S homeologs is relatively
concordant. We validated the RNA-seq data by whole-mount in situ
hybridization (WISH) (Fig. 3). Although WISH is not quantitative,
we observed a positive correspondence between FPKM values and
WISH signal intensity, with the exception of MAM domain
containing 2 (mamdc2), which we detected despite low FPKM
(Fig. 3D). Probes not detected at stage 10.5 [kielin/chordin-like
protein (kcp), hyaluronan and proteoglycan link protein 3 (hapln3)
and follistatin like 1 ( fstl1)] were validated at neurula or tailbud
stages to show correct, published expression when this information
was available on Xenbase (Karpinka et al., 2015).
znf703, znf503, kremen2 and mamdc2 are expressed in the
circumblastoporal ring, but absent from the organizer (Fig. 3A-D),
reminiscent of the expression patterns of ventx2 or wnt8 (Karpinka
et al., 2015). TTNPB intensifies and expands expression of znf703,
znf503, kremen2 and mamdc2 into the dorsal domain (Fig. 3E-H).
This result is concordant with zebrafish data showing that RA causes
the ortholog Znf703 to be ectopically expressed in the embryonic
shield (Andreazzoli et al., 2001). skida1, which normally is barely
detectable, is intensified in TTNPB-treated embryos, although its
domain is unchanged (Fig. 3I,M). Nkx6-2 is found in the dorsal lip,
and TTNPB widens and ventralizes its expression (Fig. 3J,N).
Fig. 1. RARγ1 is required for the expression
of mesoderm markers. (A-D) Embryos were
microinjected unilaterally at the 2-cell or 4-cell stage
with 3.3 ng RARγ1.S+3.3 ng RARγ1.L/S MOs
(Fig. S3). Injected side is to the right of the dashed line,
and is indicated by the magenta β-gal lineage tracer.
WISH shows that RARγ1 MOs result in the loss of T,
fgf8,wnt8 and gdf3. (E-H) Embryos weremicroinjected
unilaterally at the 2-cell or 4-cell stage with 6.6 ng
RARα2 MOs (Janesick et al., 2013). Injected side is to
the right of the dashed line, and is indicated by the
magenta β-gal lineage tracer. RARα2 MOs did not
affect T, wnt8 or gdf3 expression, but did produce loss
of N-tubulin as previously published (Janesick et al.,
2013). All embryos, except in H, are shown in vegetal
view at stage 10.5/11. H is shown in dorsal view, with
anterior on the bottom at stage 14. Fractions represent
the portion of embryos displaying the phenotype.
NC, no change.
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dhh was not previously characterized at gastrula stages; we show that
it is expressed in a punctate pattern surrounding the blastopore, and is
greatly expanded by TTNPB (Fig. 3K,O). cyp26a1 is a known direct
RAR target and serves as a positive control for the effects of
modulating RA signaling. cyp26a1 expression is expanded into the
animal domain accompanied by punctate, apparently nuclear staining
in the vegetal tissue (Fig. 3L,P).
RARγ1 functions as an activator during mesoderm
development
Considering the overlapping expression of the genes encoding the
RA-synthesizing enzyme Aldh1a2 and the RA-degrading enzyme
cyp26a1 with rarg mRNA expression (Fig. S2), we tested whether
RARγ1 was functioning as an activator or repressor in modulating
the expression of one of its targets, znf703. RARs are capable of
both direct activation or repression of target genes depending on
their proximity to ligand during development (Janesick et al., 2014).
We possess expression constructs for wild-type RARγ1 (WT
RARγ1), constitutively active RARγ1 (VP16-RARγ1, which
mimics the liganded, active form of the receptor), and dominant-
negative RARγ1 (DN-RARγ1, which mimics the unliganded,
repressive form of the receptor), which were made in a similar
manner to the RARα constructs previously described by Blumberg
et al. (1997). Microinjection of these constructs alone led to
expansion of znf703 in VP16-RARγ1-injected embryos (Fig. S5A,B)
and knockdown of znf703 by DN-RARγ1 (Fig. S5C,D). WT RARγ1
rescues znf703 expression as expected (Fig. 4C,G), and further
confirms the specificity of our morpholino. VP16-RARγ1 rescues
znf703, and expands its domain dorsally and animally (Fig. 4B,F;
Fig. S5E) whereas DN-RARγ1 does not rescue znf703 expression
(Fig. 4D,H). Therefore, we infer that RARγ1 is functioning as a
transcriptional activator during mesoderm development, and that
retinoids are likely available to the embryo at this stage, earlier than
previously recognized.
Explants from RARγ1 MO-injected embryos spontaneously
dissociate
Xenopus animal caps can be induced to become dorsal mesoderm at
high concentrations of activin (Sokol et al., 1990; Ruiz i Altaba and
Jessell, 1991). We isolated animal caps from RARγ1 MO-injected
embryos using a low-dose MO that does not elicit non-specific
effects on gastrulation. We treated the caps with activin and found
that, instead of elongating, they dissociated within 12 h irrespective of
the activin concentration, compared with control MO (Fig. 5A,B).
ncam1 expression was upregulated by activin in control embryos as
previously published (Bolce et al., 1992), but was significantly
decreased in RARγ1 MO-injected caps at 8-h post-activin treatment
(Fig. 5C), with little change in expression of the housekeeping gene
histone H4 (hist1h4d). This indicates that RARγ1 is required for
cellular adhesion and the ability of explants to elongate. Furthermore,
adhesion is also crucial for intercellular signaling required for
mesodermal competence (Gurdon, 1988; Kato and Gurdon, 1993), as
well as in boundary formation, where RAR is known to play a major
role (e.g. in somite and rhombomere border delineation).
RARγ1 knockdown terminates the myogenesis program
One of the earliest derivatives of mesodermal induction is muscle
(Gurdon et al., 1993). Soon after gastrulation begins, myod expression
occurs in presumptive muscle in response to mesoderm induction
(Hopwood et al., 1989; Harvey, 1992). Consistent with our results in
early mesoderm (Fig. 1), we found that expression of myod mRNA
was restricted and diminished on the injected side of RARγ1
MO-embryos (Fig. 6A; also see figure S13 in Janesick et al., 2014).
Generally speaking, myod WISH staining was mostly diffuse and
reduced in intensity such that the only conclusion it is possible to
make confidently is that somite boundaries have been blurred or lost.
Therefore, we employed an immunohistochemical approach to detect
Myod protein (Hopwood et al., 1992) in coronal sections. As expected,
we observed loss of unsegmented PSM expression on the injected
side (Fig. 6B), which agrees with our previous finding that RARγ
is required for the maintenance of the PSM (Janesick et al., 2014).
Despite the fact thatMyod is frequently used as a somitemarker, its
presence is insufficient to assure terminal myogenic differentiation
(Hopwood et al., 1991; Kato and Gurdon, 1993). Rather, continued
expression of Myod inhibits terminal differentiation of skeletal
muscle. We found ectopicMyod-positive nuclei throughout the trunk
of the tailbud-stage embryo (Fig. 6A). Accordingly, differentiated
skeletal muscle marked by 12/101 staining was significantly reduced
on the injected side (Fig. 6B). We conclude that loss of RARγ1
prevents the full myogenesis program from occurring and that this
phenotype is likely to be linked to deficiencies in early mesoderm
formation (see Discussion).
DISCUSSION
RARγ signaling is important in early mesoderm development
RA is not considered to be an instructive signal in mesoderm
induction, in contrast to Nodal and Wnt signaling. RA inhibits
Fig. 2. Results of RNA-seq data analysis. (A) GO analysis of differentially
expressed genes after TTNPB treatment. GO terms shown to be statistically
over-represented (P=0.001) in 1 µM TTNPB-treated embryos (q<0.05,
FPKMVEH>0.1) conducted in DAVID (Huang da et al., 2009a, b). Gene symbols
fromXenopuswere used as input, and GO termswere derived from human (for
better annotation). Enrichment score is measured by Fisher’s exact statistics
by the DAVID server. *zic1 is a downregulated gene, and zeb2, tgif2 are <1.5-
fold activated by TTNPB. (B) TTNPB-induced genes selected for further
analysis in mesoderm development. Activation by TTNPB (represented as
log2FPKM) is mapped for both .L and .S subgenomes (Matsuda et al., 2015;
Session et al., 2016). kielin and btg2 are not found in .S and .L, respectively;
hapln.S is not detected by RNA-seq.
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expression of dorsal mesoderm markers in animal caps exposed to
high doses of activin, but is unable to promote elongation of caps
alone (Ruiz i Altaba and Jessell, 1991; Sive and Cheng, 1991).
Previous research showed that RA acts during mesoderm formation
by transforming the anteroposterior value of mesoderm toward
the posterior. Nevertheless, factors that serve as permissive signals
or contribute to the competence of responding tissue are very
important for embryonic inductions, including mesoderm
induction (Fletcher and Harland, 2008). RA, in combination with
BMP4, can induce the production of mesodermal precursors from
embryonic stem cells (Torres et al., 2012), and many mesodermal
derivatives (e.g. somites, heart, kidney, gonads) are affected when
RA signaling is perturbed (Cartry et al., 2006; Hasegawa and Saga,
2012; Rhinn and Dolle, 2012, and reviewed by Cunningham and
Duester, 2015; Naylor et al., 2016). Here, we propose a new role
for RARγ signaling and show that it is required much earlier than
had been previously thought for the expression of mesodermal
markers, in vivo.
Retinoids are present in Xenopus eggs and embryos, but
their availability in early development has been controversial
(Pijnappel et al., 1993; Creech Kraft et al., 1994; Blumberg et al.,
1996). Reporter gene studies have suggested that retinoids are
not active in the embryo until neurula stages (Ang and Duester,
1999); however, 4-oxo-retinaldehyde (Blumberg et al., 1996) and
4-oxo-RA (Pijnappel et al., 1993) can activate RAR and are present
in gastrula-stage embryos. Chicken embryos also possess high
levels of RA in Hensen’s node during gastrulation (Chen et al.,
1992). Although cyp26a1 is highly expressed in the Xenopus
Fig. 3. RAR-selective agonist TTNPB modulates
expression of genes identified by RNA-seq.
(A-P) WISH from embryos treated at stage 6/7 with 1 μM
TTNPB or control vehicle (0.1% ethanol). (A-D,I-L) Control
expression of znf703, znf503, kremen2,mamdc2, skida1,
nkx6-2, dhh and cyp26a1. (E-H,M-P) TTNPB expands
expression of these genes. All embryos are shown in
vegetal view at stage 10.5/11 with dorsal lip at the top.
N, number of embryos scored in the experiment; 100%
of embryos displayed the phenotype shown.
Fig. 4. RARγ1 acts as a transcriptional activator in
rescuing znf703 expression in RARγ1 MO embryos.
(A-H) Embryos injected unilaterally at the 2- or 4-cell
stage. Injected side is to the right of the dashed line, and is
indicated by themagenta β-gal lineage tracer. (A,E) 3.3 ng
RARγ1.S+3.3 ng RARγ1.L/S MOs diminish znf703
expression. (B,F) VP16-RARγ1 mRNA (0.2 ng) rescues
and expands znf703 expression beyond its usual
boundary. (C,D,G,H) WT RARγ1 mRNA (0.5 ng) partially
rescues znf703 (C,G) and 2 ng DN-RARγ1 mRNA does
not rescue znf703 at all, and the severity of the knockdown
is increased (D,H). Embryos are shown at stage 10.5/11 in
vegetal (A-D) or dorsal (E-H) view. Fractions represent the
portion of embryos displaying the phenotype.
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circumblastoporal domain, it has not been determined whether
this enzymatic pathway is responsible for generating 4-oxo-
retinoids, in comparison with its known activity in producing
4-OH-retinoids (Shimshoni et al., 2012; Topletz et al., 2015).
We showed that only the wild-type and constitutively active forms
of RARγ1 rescued mesodermal markers (e.g. znf703) in RARγ1-
knockdown embryos. As the constitutively active form of RARγ1
mimics liganded RARγ1, our results suggest that retinoids are
available to the embryo (at least locally) at gastrula stages, unless
the receptor functions as an unliganded activator, which would be
unprecedented for an RAR.
Novel RAR targets in early mesoderm development
We identified several novel targets expressed in the circumblastoporal
region that are upregulated by RAR signaling in the early gastrula.
znf703, znf503, kremen2 and mamdc2 are normally absent from
the dorsal organizer, but are ectopically expanded there in the
presence of RA. Hence, RAventralizes dorsal tissue duringmesoderm
development, a phenomenon already recognized in later stages, as
RA-treated embryos display a bauchstuck (ventralized) phenotype
(Durston et al., 1989; Sive et al., 1990). RA also expanded the
expression domain of the ventral patterning gene nkx6-2. This is
concordant with the observation thatNkx6.2 is reduced in vitamin A-
deficient quail as well as RAR antagonist-treated chicken embryos
(Diez del Corral et al., 2003; Bayha et al., 2009).
Kremen2 is the receptor for Dickkopf, a Wnt inhibitor that
mediates mesendoderm internalization and promotes head
mesoderm and cardiac fate (Schneider and Mercola, 2001).
skida1, a DACH/dachshund-related gene of unknown function,
was more ubiquitously expressed than other markers, but highly
responsive to RA. Its expression in the pronephric kidney at later
stages (Seufert et al., 2005) could indicate a potential role of skida1
in responding to RA signaling in pronephric precursors. dhh is a
hedgehog gene important for mammalian Leydig cell differentiation
(reviewed by Franco and Yao, 2012), and is highly expressed in
Xenopus testis (Haselman et al., 2015). These findings could
provide molecular mechanisms linking RA signaling with
intermediate mesoderm and gonadal development.
Our results show that RARγ1MO inhibits cell adhesion in animal
caps which has important implications for numerous developmental
processes, such as the morphogenic movements of gastrulation and
the formation of somite or rhombomere boundaries. Two of the
targets identified in our RNA-seq dataset regulate adhesion.
Although the function of mamdc2 is not well characterized, the
MAM domain is found in proteins that regulate cell adhesion and
Fig. 5. RARγ1 MO inhibits cell adhesion in animal caps. (A-C) Embryos
were injected bilaterally at the 2-cell stage with 3.3 ng RARγ1.S+3.3 ng
RARγ1.L/S MOs. Animal caps were harvested at stage 9 and incubated in
control vehicle or defined doses of activin (0.8, 4, 20 and 100 ng/ml) overnight.
(A,B) RARγ1 MOs result in animal cap dissociation (note the large number of
single cells) (B), compared with control MO (A) in all treatment conditions. This
effect was replicated in three separate experiments. mRNAwas harvested 8 h
after treatment from the third and final animal cap experiment and evaluated as
shown in C. (C) ncam1 expression was significantly reduced in RARγ1 MO
animal caps compared with control MO, despite constant housekeeping
(histone H4) expression. The upper y-axis represents ncam1 expression 2−ΔCt
values normalized to histone H4. The bottom y-axis shows raw Ct values of
histone H4.
Fig. 6. RARγ1 knockdown yields a complex phenotype on myod mRNA
and Myod protein. Embryos were injected unilaterally at 2- or 4-cell stage.
(A) Injection of 3.3 ng RARγ1.S+3.3 ng RARγ1.L/S MOs lead to reduced
Myod mRNA expression (10/14 embryos, dorsal view). (B) RARγ1 MOs
cause loss of PSM expression of Myod protein and ectopic expression in the
trunk of coronal sections of stage 26 embryos (4/4 embryos). (C) RARγ1 MOs
cause loss and disorganization of mature somite marker 12/101 in coronal
sections of stage 26 embryos (4/4 embryos).
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motility, such as zonadhesin and nephronectin (Beckmann andBork,
1993). znf703 is implicated in epithelial-mesenchymal transitions
(EMTs), downregulates E-cadherin (cdh1), and increases cell
invasion/motility (Holland et al., 2011; Slorach et al., 2011; Shahi
et al., 2015). Although mesoderm formation in Xenopus is not
considered to be a classical EMT (Nakaya and Sheng, 2008), the
transformation of epithelioid cells to mobile mesenchymal cells
during Xenopus gastrulation undoubtedly requires genes that
regulate cell adhesion and morphogenesis, such as znf703. znf703
is also expressed in somites and the neural plate border (Hong and
Saint-Jeannet, 2017). Therefore, regulation of znf703 by RA might
be important for the epithelialization of somites as well as neural
crest migration.
RARγ and mesodermal development – the bigger picture
RA can act late on myoblast, cardiac, renal or gonadal progenitor
populations to affect specification or differentiation, but our
results open the possibility that RARγ acts earlier to promote
mesodermal fates. Loss of adhesion and subsequent dissociation
in explants from RARγ1 MO-injected embryos is likely to disrupt
the ‘community effect’ (intercellular signaling), which has been
shown to be important for myogenic differentiation and the early
stages of somitogenesis (Gurdon, 1988; Cossu et al., 1995). In these
early studies, myogenic commitment was not solely determined
by inducing signals, but additional signals (e.g. embryonic FGF
ligand) within the responding tissue (Symes et al., 1988; Standley
et al., 2001). One of the earliest mesodermal genes upregulated
after induction is Myod, but expression of Myod alone doth not a
muscle make (Hopwood et al., 1991). The fact that the injected
side of RARγ1 MO tailbud embryos still expresses Myod without
12/101 indicates that cells have not received the appropriate
signals (even if only from each other) to fully stabilize myogenic
commitment and terminal differentiation.
In line with our previous findings (Janesick et al., 2014),
injection of RARγ1 MO led to an absence of Myod protein in
nuclei of the unsegmented PSM. This is expected because
RARγ1 is known to play an important role in the maintenance of
chordoneural hinge and unsegmented PSM (Janesick et al., 2014).
However, we also observed that in RARγ1 MO-injected embryos,
Myod+ cells were found ectopically in the trunk, which could
indicate that PSM identity is transformed rostrally. Alternatively, the
presence of Myod+ cells without somite maturation (as indicated
by 12/101 staining) suggests that the muscle differentiation
program commences, but cannot finish. In this scenario, RARγ1
loss of function might actually stabilize the muscle progenitor
state, thus hindering somite maturation, or Myod might require
RARγ1 for its degradation.
Unlike other manipulations of RA signaling (chemical treatment,
RARβ MO injection, overexpression of constitutively active or
dominant-negative RARα or RARγ), which shift somitomere
boundaries or alter somitomere size (Moreno and Kintner, 2004;
Janesick et al., 2014), or chevron morphology (Janesick et al.,
2017), loss of RARγ is the only manipulation of RA signaling that
completely precludes any somite boundaries from forming.
Furthermore, genes that normally regulate boundary formation,
such as ripply2 and thyl2 (mespa) are barely detectable in RARγ
MO-injected embryos (Janesick et al., 2014). The RARγ MO-
induced dissociation of explants is a clue that cellular adhesion, an
important component of boundary formation, is perturbed.
Furthermore, somite maturation requires Myod degradation for
proper somite epithelialization and boundary formation. Continued
ectopic Myod expression observed on the injected side of RARγ1
MO-injected tailbud embryos is likely to completely thwart a
successful myogenic program.
Our finding that RARγ is required for the expression of early
mesodermal markers opens the possibility that RA signaling
provides a more instructive role, as opposed to simply providing
positional cues to already committed tissue. Current guidance
protocols for making mesoderm or muscle from stem cells in
culture currently do not utilize RA (Chal et al., 2016; Loh et al.,
2016). Our results suggest that RA signaling could be exploited
in mesoderm formation, but with careful attention to specificity
of receptor subtypes. As new receptor-selective ligands are
developed (Tsang et al. 2003; Shimono et al., 2011), it will be
interesting to consider whether mesodermal lineages can be further
manipulated, stabilized or specialized based on the results provided
here and an increased understanding of how RA receptors actually
function in development.
MATERIALS AND METHODS
RNA-seq
Eggs from one clutch of female X. laeviswere fertilized in vitro and embryos
were staged as described (Janesick et al., 2014). Stage 6-7 embryos were
treated in groups of 25 in 60-mm glass Petri dishes with 10 ml of 0.1× MBS
containing 1 μM RAR-selective agonist TTNPB (Tocris), 1 μM RAR-
selective inverse agonist (antagonist) AGN193109 (a gift from Dr Rosh
Chandraratna, IO Therapeutics; Arima et al., 2005) or vehicle control (0.1%
ethanol). Each dish was harvested at gastrula stage 10.5 in five-embryo
aliquots; each aliquot was designated as n=1 biological replicate. Replicates
were taken from two different clutches, and five replicates were analyzed
within each clutch (ten replicates in total). Approximately ten embryos from
each chemical treatment were reserved and aged until stage 40 to verify that
the chemicals resulted in strong retinoid phenotypes as previously published
(Koide et al., 2001).
Each five-embryo pool was homogenized in 200 μl of TriPure (Roche).
Total RNAwas DNAse treated, LiCl precipitated, and 100 ng was reverse
transcribed into cDNA using Ovation RNA Amplification System
V2 (NuGEN). Deep-sequencing libraries with barcode indices were
synthesized using ABI SOLiD 5500 Fragment Library Core Kit and
subjected to 50-nucleotide, single-read multiplex sequencing with ABI
SOLiD 5500XL deep sequencers (Aceto, et al., 2014). The Bowtie,
TopHat and Cufflinks pipeline was used (Trapnell et al., 2012), and
expression data deposited in Gene Expression Omnibus under accession
number GSE119124. Differential gene expression analysis (TTNPB or
AGN193109 versus control) was conducted using CyberT (Kayala and
Baldi, 2012) to facilitate comparison with our previously published
microarray datasets (Arima et al., 2005; Janesick et al., 2014). We
employed VSN normalization and performed unpaired two-conditions
data analysis on FPKM (fragments per kilobase per million mapped reads)
values for 1 μM TTNPB versus vehicle control, and 1 μM AGN193109
versus vehicle control. q-values from differential expression analysis are
reported as Benjamini–Hochberg-corrected P-values. The full dataset of
differentially expressed genes is available in Tables S1 (1 μM TTNPB)
and S2 (1 μM AGN193109). We conducted GO analysis using DAVID
(Database for Annotation, Visualization and Integrated Discovery; Huang
da et al., 2009a, b).
Embryo microinjection and in situ hybridization
Xenopus eggs were fertilized in vitro and embryos were staged as described
(Janesick et al., 2012). Embryos were microinjected bilaterally or
unilaterally at the two- or four-cell stage with gene-specific MOs
(Table S3) and/or mRNA together with 100 pg/embryo β-galactosidase
(β-gal) mRNA lineage tracer. Both morpholinos against RARγ1 yield the
same knockdown phenotype on znf703 (Fig. S3). Embryos were maintained
in 0.1× MBS until appropriate stages. Embryos processed for WISH were
fixed in MEMFA (10% 10× MEMFA salt, 10% formaldehyde, 80% DEPC
water), stained with magenta-GAL (Biosynth), and then stored in 100%
ethanol (Janesick et al., 2012).
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WISH was performed on microinjected embryos as previously described
(Janesick et al., 2012). fgf8 probe (courtesy of Nancy Papalopulu, University
of Manchester, UK) was linearized with BamHI. All other probes were
prepared by PCR amplification of protein-coding regions (∼500-800 bp)
from either cDNA or library clones with a bacteriophage T7 promoter at the
3′ end. Relevant primers are listed in Table S4. Probes were transcribed with
MEGAscript T7 (Life Technologies) in the presence of digoxigenin-11-
UTP (Roche) as previously described (Janesick et al., 2012).
Animal cap assays
Microinjected animal caps were explanted at stage 8-9 and collected into 1%
agarose, 0.4× MBS Petri dishes. Each cap was transferred to individual
depressions created in a 1% agarose-coated 6-well plate, in 0.4× MBS plus
activin treatment (R&D Systems recombinant Activin A) or control vehicle.
After overnight incubation (∼10 h), animal caps were homogenized in
200 μl TriPure (Roche). Total RNA was DNAse treated, LiCl precipitated,
reverse transcribed into cDNA, and quantified in a Light Cycler 480 System
(Roche) using ncam1 and histone H4 primer sets listed in Table S5 and
SYBR green detection. Quantitative PCR data were analyzed by 2−ΔCt
relative to histone H4 (Schmittgen and Livak, 2008).
Immunohistochemistry on vibratome sections
Embryos were embedded in 4% low-melt agarose (Bio-Rad, 1613111) in
1× PBS under a dissection microscope in disposable molds (VWR, 15160-
215). The embryos were sectioned coronally in cold 1× PBS using a Leica
VT1200 vibratome (50 µm thickness, 1 mm amplitude, 0.5 mm/s speed).
Free-floating vibratome sections were immunostained in mesh-bottomed
baskets. Sections were permeabilized (0.5% Triton X-100) for 30 min
then blocked (1% bovine serum albumin, 0.2% Triton X-100) in 1× PBS at
room temperature. Incubation in primary antibody against either Myod
(1:3) or 12/101 (1:10) (Developmental Studies Hybridoma Bank) was
carried out in blocking buffer overnight at 4°C. Sections were washed
three times for 15 min each wash in 0.2% Triton X-100 in 1× PBS then
incubated in secondary antibody (donkey anti-mouse Alexa Fluor 647 1:200;
Thermo Fisher Scientific) along with DAPI nuclear stain (1:2000). After
washing again, sections were mounted on glass slides in antifade medium
with 0.12 mm spacer (Thermo Fisher Scientific, S24735). Sections were
imaged at 1.0 zoom on the Zeiss LSM880 confocal microscope at 20×
magnification (Plan-Apochromat 1.3 numerical aperture) using a tiling
stage and Zeiss Zen Black acquisition software.
Acknowledgements
We thank Dr Stefan Heller (Stanford University) for generous use of his lab’s
Leica VT1200 vibratome and the Stanford Otolaryngology Imaging Core (Lars
Becker) for use of the Zeiss LSM700 confocal microscope, which were essential
for Fig. 6 of this manuscript.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: A.J., B.B.; Methodology: A.J., B.B.; Software: T.S.; Validation:
A.J.,W.T., B.B.; Formal analysis: A.J., W.T., T.S.; Investigation: A.J., W.T., T.S., B.B.;
Resources: A.J., T.S., B.B.; Data curation: T.S.; Writing - original draft: A.J.; Writing -
review & editing: A.J., B.B.; Visualization: A.J., W.T.; Supervision: A.J., B.B.; Project
administration: A.J., B.B.; Funding acquisition: T.S., B.B.
Funding
This work was supported by grants from the National Science Foundation
(IOS-0719576, IOS-1147236 to B.B.). A.J. is currently supported by the
A.P. Giannini Foundation.
Data availability
RNA-seq data have been deposited in Gene Expression Omnibus under accession
number GSE119124.
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.147769.supplemental
References
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S.,
Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H. et al. (2014). Circulating
tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell
158, 1110-1122.
Andreazzoli, M., Broccoli, V. and Dawid, I. B. (2001). Cloning and expression of
noz1, a zebrafish zinc finger gene related to Drosophila nocA. Mech. Dev. 104,
117-120.
Ang, H. L. and Duester, G. (1999). Stimulation of premature retinoic acid synthesis
in Xenopus embryos following premature expression of aldehyde dehydrogenase
ALDH1. Eur. J. Biochem. 260, 227-234.
Arima, K., Shiotsugu, J., Niu, R., Khandpur, R., Martinez, M., Shin, Y., Koide, T.,
Cho, K. W., Kitayama, A., Ueno, N. et al. (2005). Global analysis of RAR-
responsive genes in the Xenopus neurula using cDNA microarrays. Dev. Dyn.
232, 414-431.
Bayha, E., Jørgensen, M. C., Serup, P. and Grapin-Botton, A. (2009). Retinoic
acid signaling organizes endodermal organ specification along the entire antero-
posterior axis. PLoS One 4, e5845.
Beckmann, G. and Bork, P. (1993). An adhesive domain detected in functionally
diverse receptors. Trends Biochem. Sci. 18, 40-41.
Blumberg, B., Bolado, J., Jr, Derguini, F., Craig, A. G., Moreno, T. A.,
Chakravarti, D., Heyman, R. A., Buck, J. and Evans, R. M. (1996). Novel
retinoic acid receptor ligands in Xenopus embryos. Proc. Natl. Acad. Sci. USA 93,
4873-4878.
Blumberg, B., Bolado, J., Jr, Moreno, T. A., Kintner, C., Evans, R. M. and
Papalopulu, N. (1997). An essential role for retinoid signaling in anteroposterior
neural patterning. Development 124, 373-379.
Bolce, M. E., Hemmati-Brivanlou, A., Kushner, P. D. and Harland, R. M. (1992).
Ventral ectoderm of Xenopus forms neural tissue, including hindbrain, in response
to activin. Development 115, 681-688.
Cartry, J., Nichane, M., Ribes, V., Colas, A., Riou, J. F., Pieler, T., Dolle, P.,
Bellefroid, E. J. andUmbhauer, M. (2006). Retinoic acid signalling is required for
specification of pronephric cell fate. Dev. Biol. 299, 35-51.
Chal, J., Al Tanoury, Z., Hestin, M., Gobert, B., Aivio, S., Hick, A., Cherrier, T.,
Nesmith, A. P., Parker, K. K. and Pourquie, O. (2016). Generation of human
muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.
Nat. Protoc. 11, 1833-1850.
Chen, Y., Huang, L., Russo, A. F. and Solursh, M. (1992). Retinoic acid is enriched
in Hensen’s node and is developmentally regulated in the early chicken embryo.
Proc. Natl. Acad. Sci. USA 89, 10056-10059.
Cossu, G., Kelly, R., Di Donna, S., Vivarelli, E. and Buckingham, M. (1995).
Myoblast differentiation during mammalian somitogenesis is dependent upon a
community effect. Proc. Natl. Acad. Sci. USA 92, 2254-2258.
Creech Kraft, J., Schuh, T., Juchau, M. R. and Kimelman, D. (1994). “Temporal
distribution, localization and metabolism of all-trans-retinol, didehydroretinol and
all-trans-retinal during Xenopus development.” Biochem J 301, 111-119.
Cunningham, T. J. and Duester, G. (2015). Mechanisms of retinoic acid
signalling and its roles in organ and limb development. Nat. Rev. Mol. Cell Biol.
16, 110-123.
DeDomenico, E., Owens, N. D., Grant, I. M., Gomes-Faria, R. andGilchrist, M. J.
(2015). Molecular asymmetry in the 8-cell stage Xenopus tropicalis
embryo described by single blastomere transcript sequencing. Dev. Biol.
408, 252-268.
Diez del Corral, R., Olivera-Martinez, I., Goriely, A., Gale, E., Maden, M. and
Storey, K. (2003). Opposing FGF and retinoid pathways control ventral neural
pattern, neuronal differentiation, and segmentation during body axis extension.
Neuron 40, 65-79.
Durston, A. J., Timmermans, J. P., Hage, W. J., Hendriks, H. F., de Vries, N. J.,
Heideveld, M. and Nieuwkoop, P. D. (1989). Retinoic acid causes an
anteroposterior transformation in the developing central nervous system. Nature
340, 140-144.
Evans, R. M. and Mangelsdorf, D. J. (2014). Nuclear receptors, RXR, and the big
bang. Cell 157, 255-266.
Fletcher, R. B. and Harland, R. M. (2008). The role of FGF signaling in the
establishment and maintenance of mesodermal gene expression in Xenopus.
Dev. Dyn. 237, 1243-1254.
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